Publication Date
June 2008
Recommended Citation
W. Martin Kast, "VEEV Replicon-Based Vaccines Used in Heterologous Prime Boost Strategies Induce Lifelong Protection Against Prostate Cancer and Therapy of Cervical Cancer in Mice and Robust Cell-Mediated Immunity in Rhesus macaques" in "Vaccine Technology II", Barry C. Buckland, Merck & Co., Inc.; John G. Auniņš, Merck & Co., Inc.; Paula Marques Alves, ITQB/IBET; Kathrin U. Jansen, Wyeth Vaccine Research Eds, ECI Symposium Series, (2008). https://dc.engconfintl.org/vaccine/4
COinS
